The State of Bladder Cancer Awareness and Research

Endoscopy Insights Podcast

The State of Bladder Cancer Awareness and Research

"It's a serious condition, highly prevalent condition, and the fact that it increases with aging in our population that is aging, has resulted in the incidents increasing rather than decreasing."

May was Bladder Cancer Awareness Month, so we wanted to share a conversation with Dr. Yair Lotan on the state of bladder cancer awareness and research, his work with the Bladder Cancer Advocacy Network, and some of the advancements in bladder cancer research that most excite him.

Dr. Lotan is a urology professor and chief of urologic oncology at University of Texas Southwestern Medical Center in Dallas, Texas. He’s known nationally for his research on urine markers and molecular markers, which will help determine patients at higher risk for recurrent cancer. 

Bladder cancer is the sixth most common cancer diagnosed annually in the U.S., according to the National Library of Medicine.

This is the second part of a two-part conversation we conducted with Dr. Lotan. In the first, we discussed a micro-cost analysis published in Urology that broke down per-procedural costs for cystoscopy and explored how single-use cystoscopes might provide a cost-effective option for providers.

Dr. Lotan is an Ambu consultant.

Show notes:

------------------------

Endoscopy Insights is a podcast devoted to conversations with thought leaders in flexible and single-use endoscopy. In each episode we’ll explore the ways different clinical and technological innovations are moving the field of endoscopy forward.       

Endoscopy Insights is brought to you by Single-Use Endoscopy, part of the Ambu Learning Center. Ambu has been bringing healthcare solutions of the future to life since 1937.

Subscribe to the Endoscopy Insights Podcast

          

Click here to view all episodes

More Endoscopy Insights Episdoes
The State of Bladder Cancer Awareness and Research
Endoscopy Insights Podcast
Bladder cancer is the sixth most common cancer diagnosed annually in the U.S., according to the National Library of Medicine. Dr. Yair Lotan joins us again to discuss the state of bladder cancer awareness and research.
The FDA’s Safety Communication Update for Reprocessing Bronchoscopes
Endoscopy Insights Podcast
The U.S. Food and Drug Administration recently updated a safety communication on reprocessing flexible bronchoscopes. To break down this announcement and what it means, we talked to Dr. Hudson Garrett, an infection prevention and control expert.
The Evolution of Single-Use Urologic Endoscopy
Endoscopy Insights Podcast
Dr. Michael Lipkin discusses a recent study that found that a new single-use cystoscope demonstrated superior flexion and comparable optics to the reusable scopes already being used in a hospital urology department.
More From Single-Use Endoscopy
What is the ‘Holiday Effect’ on ERCPs?

Gastrointestinal Endoscopy Procedure

Researchers have found certain post-ERCP complications to be more frequent in December. But why?

Medicare penalties for high readmissions are lower than they have been, but still affect nearly 2,300 U.S. hospitals.

Value-Based Care

Lowering readmission rates remains a national priority for payers, providers and policymakers seeking to improve healthcare while reducing costs.

Doctor at desk with calculator and computer

Analyzing Value

The authors of a recent review found that routine repair is costly and may cause delays in service while reusable devices are unavailable. Specialized equipment and staff are needed for sterilization — and inadequate cleaning increases infection risk.